CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-03 | Ho Carole Chief Medical Officer | Grant or award · Stock Option (right to buy) | +161,160 | 161,160 | ||
| 2024-01-03 | Watts Ryan J. President and CEO | Grant or award | +89,520 | 272,957 | ||
| 2024-01-03 | Watts Ryan J. President and CEO | Grant or award · Stock Option (right to buy) | +268,560 | 268,560 | ||
| 2023-12-15 | SATO VICKI L Director | Sale 10b5-1 | −1,666 | $23.39 | $39K | 124,707 |
| 2023-11-15 | SATO VICKI L Director | Sale 10b5-1 | −1,666 | $19.13 | $32K | 126,373 |
| 2023-10-16 | SATO VICKI L Director | Sale 10b5-1 | −1,666 | $20.66 | $34K | 128,039 |
| 2023-09-15 | SATO VICKI L Director | Sale 10b5-1 | −1,626 | $23.60 | $38K | 129,745 |
| 2023-09-15 | SATO VICKI L Director | Sale 10b5-1 | −40 | $24.35 | $974 | 129,705 |
| 2023-08-23 | Schuth Alexander O. COFO and Secretary | Sale | −2,522 | $23.17 | $58K | 518,989 |
| 2023-08-23 | Ho Carole Chief Medical Officer | Sale | −2,522 | $23.22 | $59K | 182,809 |
| 2023-08-21 | Ho Carole Chief Medical Officer | Sale | −2,478 | $22.60 | $56K | 185,331 |
| 2023-08-21 | Schuth Alexander O. COFO and Secretary | Sale | −2,478 | $22.59 | $56K | 521,511 |
| 2023-08-21 | Watts Ryan J. President and CEO | Sale | −2,309 | $22.59 | $52K | 2,242,604 |
| 2023-08-21 | Krognes Steve E. Director | Sale | −1,419 | $22.60 | $32K | 145,799 |
| 2023-08-15 | SATO VICKI L Director | Sale 10b5-1 | −1,666 | $24.30 | $40K | 131,371 |
| 2023-08-14 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −2,768 | $23.79 | $66K | 182,809 |
| 2023-08-14 | Schuth Alexander O. COFO and Secretary | Sale | −2,772 | $23.67 | $66K | 518,989 |
| 2023-08-10 | Watts Ryan J. President and CEO | Option exercise | +2,526 | $0.68 | $2K | 2,242,439 |
| 2023-08-10 | Watts Ryan J. President and CEO | Sale | −2,526 | $25.03 | $63K | 2,239,913 |
| 2023-08-10 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) | −2,526 | 1,118,091 |
Page 9 of 53 · 1,043 trades